trending Market Intelligence /marketintelligence/en/news-insights/trending/kht0vpmqruyevooe_2g_gg2 content esgSubNav
In This List

Billionaire Jack Ma's Yunfeng Capital, Alibaba to take iKang Healthcare private

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Billionaire Jack Ma's Yunfeng Capital, Alibaba to take iKang Healthcare private

IKang Healthcare Group Inc. will go private after being acquired by two entities owned by Chinese billionaire Jack Ma.

Private equity firm Yunfeng Capital and e-commerce giant Alibaba Group Holding Ltd. entered definitive agreements to buy the Beijing-based healthcare services provider for $41.20 per common share or $20.60 for every American depositary stock acquired.

Jack Ma is the co-founder of both Yunfeng Capital and Alibaba.

IKang will be delisted from Nasdaq once the acquisition goes through, expected in the third quarter of the year.

J.P. Morgan Securities (Asia Pacific) Ltd., Simpson Thacher & Bartlett LLP, Walkers and Junhe LLP advised the iKang board on the deal. Davis Polk & Wardwell LLP and King & Wood Mallesons are serving as legal counsel to iKang.

Wilson Sonsini Goodrich & Rosati and Fangda Partners are serving as legal counsel to the buyers.